About MATMED s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at MATMED s.r.o.
During the past decade, MATMED s.r.o. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
2003-11-01
2007-10-01
Completed
1,306
Efficacy and Feasibility of an Intermittent Weight Loss Program.
2005-09-01
2007-06-01
Completed
20
Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo
2015-01-15
2017-10-09
Completed
128
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.
2015-01-21
2017-10-10
Completed
329
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
2016-07-01
2018-09-28
Terminated
1,722
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at MATMED s.r.o.
According to Clinical.Site data, the most researched conditions in "MATMED s.r.o." are
"Atrial Fibrillation" (1 trials), "Prevention of Stroke or Systemic Embolism" (1 trials) and "Venous Leg Ulcer" (1 trials). Many other conditions were trialed in "MATMED s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at MATMED s.r.o.
Most popular intervention types in "MATMED s.r.o." are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials), "Asundexian matching placebo" (1 trials) and "Placebo Oral Tablet" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MATMED s.r.o.
The vast majority of trials in "MATMED s.r.o." are
2 trials for "All" genders.
Clinical Trials Status at MATMED s.r.o.
Currently, there are NaN active trials in "MATMED s.r.o.".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in MATMED s.r.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MATMED s.r.o., 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".